Tilray Inc
Drug Manufacturers - Specialty & Generic
Healthcare
TLRY
875 M shares
NASDAQ US
traded
08 Jan 2025
listed
no
open
1.43
52 week high
2.85
high
1.44
52 week low
1.16
low
1.34
growth
-26.74 %
previous Close
1.45
P/E ratio
market cap
1.29 B
div yield
0
usd
Aug 2024
qoq
revenue
200 M
-12.98 %
net incoming
-39.17 M
-23.37 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
-19.58 %
-5.00 %
operating incoming
-36.57 M
-77.54 %
net change in cash
-23.15 M
-128.21 %
cash on hand
205 M
-10.14 %
cost of revenue
140 M
-15.76 %
top top